WuXi AppTec launches closed process CAR-T platform
The cell therapy platform will provide development, manufacturing and release services to companies working on CAR-T therapies.
The cell therapy platform will provide development, manufacturing and release services to companies working on CAR-T therapies.
The $231m deal will initially cover commercial production of one biologic before adding additional products.